Titer
Back to Titer

The 3-Compound Cliff

Where protocol complexity becomes unmanageable

6 min read

One compound is simple. Two compounds are manageable. Three compounds is where most tracking systems fail. It's not a linear increase in complexity. It's a cliff.

The Complexity Explosion

CompoundsDecisions/DayVariables to TrackInteraction Pairs
12-34-50
25-710-121
312-1820-253
420-3035-406
5+30+50+10+

Interaction pairs grow as n(n-1)/2. At 5 compounds, you have 10 pairs of potential timing conflicts, dosing interactions, and site competition.

Titer was built for the 3-compound cliff.

Multi-compound scheduling with cycling, titration, and site rotation.

Try It Free

What Makes 3 the Breaking Point

Different Frequencies Collide

A typical 3-compound stack:

  • BPC-157: twice daily
  • CJC-1295/Ipamorelin: nightly (5 on / 2 off)
  • Semaglutide: once weekly

That's 3 different frequencies (2x/day, 1x/day with cycling, 1x/week) creating a schedule that never repeats cleanly on a weekly basis. The 5/2 cycling means the pattern shifts every 7 days relative to the calendar.

Titration Phases Overlap

Semaglutide titrates every 4 weeks. If you started BPC-157 in week 2 of your semaglutide phase, you now have two independent titration timelines that never align. When something changes (side effects, effectiveness), you can't isolate which compound's dose change caused it.

Inventory Depletion Rates Diverge

Each compound runs out at a different rate:

BPC-157 (5mg, 250mcg 2x/day): 10 days per vial
CJC-1295 (2mg, 100mcg/day, 5/2): ~28 days per vial
Semaglutide (5mg, 0.5mg/wk): 10 weeks per vial

You need to reorder BPC every 10 days, CJC every month, and semaglutide every 2.5 months. Missing any one creates an unplanned gap.

Site Pressure Multiplies

1 compound at 2x/day = 14 injections/week. Add CJC at 5x/week = 19 total. Add semaglutide weekly = 20. That's 20 injections per week competing for 8-12 subcutaneous sites.

How People Cope (and Why It Fails)

  • Memory - Works for 1-2 compounds. At 3+, you forget which CJC cycling day you're on within a week.
  • Phone reminders - “Take BPC” at 7 AM and 7 PM. Doesn't handle cycling days, site selection, or inventory.
  • Spreadsheets - Captures the data but requires active maintenance. One missed entry and confidence in the log collapses.
  • Notes app - Becomes a wall of text within days. No structure for querying “what's due today?”

Each coping mechanism hits its ceiling at 3 compounds because the question changes. It's no longer “did I take my injection?” It becomes “what combination of compounds, at what doses, at which sites, on which cycling days, is due right now?”

The Real Cost of the Cliff

When tracking fails at 3+ compounds, the cascade is:

  1. Missed doses - Not maliciously, just forgetting the evening CJC because dinner ran late
  2. Incorrect cycling - Taking CJC on a rest day because you lost count
  3. Site concentration - Defaulting to familiar sites when you can't remember which ones were used recently
  4. Inventory surprises - Running out of BPC mid-cycle with 3-day shipping delay
  5. Protocol abandonment - The cognitive load exceeds the perceived benefit, and you drop a compound or quit entirely

Protocol abandonment is the hidden failure mode. Users don't fail because compounds don't work. They fail because the operational complexity of managing them exceeds their willingness to maintain manual systems.

What Solves It

The answer isn't better willpower or more detailed spreadsheets. It's a system that:

  • Understands compound-specific scheduling rules (daily, cycling, weekly, titration)
  • Answers “what's due now?” across all active compounds simultaneously
  • Tracks site usage and suggests the next available site
  • Forecasts inventory depletion per compound independently
  • Handles the state: which cycling day, which titration phase, which sites are recovering

Related

Titer was built for the 3-compound cliff.

Multi-compound scheduling with cycling, titration, site rotation, and inventory. One unified view.

See Plans & Pricing

Disclaimer: Educational content, not medical advice. Consult a healthcare provider for protocol guidance.

Titer — protocol management for serious users.